Presentation NY Valves 2024 The Lifetime Management of Aortic Stenosis: The Unmet Needs Presenter: Sammy Elmariah June 05, 2024
Presentation NY Valves 2024 The Lifetime Management of Aortic Stenosis: A Heart Team Perspective Presenter: Michael J. Reardon June 05, 2024
News Conference News HRS 2024 LEADR: Small Diameter ICD Lead Meets Efficacy and Safety Thresholds L.A. McKeown May 27, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Conference News ACC 2024 TAVI, SAVR Rates Roughly Equal for Patients Younger Than 65 in New England Yael L. Maxwell April 05, 2024
News Daily News FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation Michael O'Riordan February 13, 2024
News Conference News STS 2024 Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3 Yael L. Maxwell February 09, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Conference News STS 2024 TAVI, SAVR Almost Equally Performed in California Patients Under 60 Yael L. Maxwell February 01, 2024
News Daily News Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details Michael O'Riordan January 25, 2024
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Daily News Ross Procedure Offers ‘Excellent Survival’ 25 Years Out Caitlin E. Cox November 15, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
Presentation TCT 2023 TCT 396: Calcification Patterns in TAVR Explants: Informing Durability & Implications for Reintervention Presenter: Stephanie Sellers October 25, 2023
Presentation TCT 2023 Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR) Presenter: Michael Reardon October 25, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023